Swimmer's Ear Treatments

Find Swimmer's Ear Treatments

Generic Name

Fluocinolone Acetonide

Brand Names
Derma-Smoothe, Dermotic, Flac, Iluvien, Neo-Synalar, Synalar, YUTIQ
FDA approval date: June 11, 1963
Classification: Corticosteroid
Form: Ointment, Cream, Oil, Implant, Solution

What is Derma-Smoothe (Fluocinolone Acetonide)?

INDICATION AND USAGE Derma-Smoothe/FS ® is a low to medium potency corticosteroid indicated: In adult patients for the treatment of psoriasis of the scalp .

Top Global Experts

There are no experts for this drug

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy

Summary: This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma with iodine-125 plaque brachytherapy.

Corticosteroid for Diabetic Macular Edema (DME) Study

Summary: Our current goals include confirming inflammation mediators are biomarkers of DR and DME The Aim of this project is to measure aqueous PGE2 and inflammatory cytokines before and after treatment of DME with intravitreal corticosteroid injections. We want to continue the study for one more year as our initial data analysis from the original INSPIRE study shows a possible direct correlation between a...

Safety and Efficacy of Topical Bacteriotherapy for Atopic Dermatitis Using Staphylococcus Hominis A9

Summary: This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and pediatric participants with atopic dermatitis. The primary safety objective of this study is to compare the safety profile of ShA9 to p...

Brand Information